Accessibility Menu
 

Biocept

(OTC) BIOCQ

Current Price$0.00
Market Cap$300
Since IPO (2014)-100%
5 Year-100%
1 Year+0%
1 Month+0%

Biocept Financials at a Glance

Market Cap

$300

Revenue (TTM)

$8.02M

Net Income (TTM)

$39.42M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

4677.57 (High)

Price

$0.00

Volume

13

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.10

BIOCQ: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Biocept

Industry

Biotechnology

Employees

52

CEO

Samuel D. Riccitelli

Headquarters

San Diego, CA 92121, US

BIOCQ Financials

Key Financial Metrics (TTM)

Gross Margin

-10%

Operating Margin

-1%

Net Income Margin

-1%

Return on Equity

0%

Return on Capital

-1%

Return on Assets

-1%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$300.00

Shares Outstanding

2.63M

Volume

13

Short Interest

0.00%

Avg. Volume

471.574

Financials (TTM)

Gross Profit

$2.58M

Operating Income

$31.98M

EBITDA

$30.24M

Operating Cash Flow

$13.29M

Capital Expenditure

$807.00K

Free Cash Flow

$14.10M

Cash & ST Invst.

$12.90M

Total Debt

$12.11M

Biocept Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2023YOY CHG

Revenue

$589.00K

N/A

Gross Profit

$1.96M

N/A

Gross Margin

-3.33%

N/A

Market Cap

$300.00

N/A

Market Cap/Employee

$6.00

N/A

Employees

50

N/A

Net Income

$3.63M

N/A

EBITDA

$2.92M

N/A

Quarterly Fundamentals

Name
Q2 2023YOY CHG

Net Cash

$4.96M

N/A

Accounts Receivable

$800.00K

N/A

Inventory

$551.00K

N/A

Long Term Debt

$9.69M

N/A

Short Term Debt

$1.91M

N/A

Return on Assets

-1.04%

N/A

Return on Invested Capital

-1.26%

N/A

Free Cash Flow

$3.18M

N/A

Operating Cash Flow

$3.09M

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
OMDDOrmand Industries Inc
$0.00+0.00%
NMSCANutrition Management Services Company
$0.00+0.00%
CWWBFPlant-Based Investment Corp.
$0.00+0.00%
BSPMBiostar Pharmaceuticals, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%
QQQInvesco QQQ Trust
$582.06-0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.12-0.07%

Questions About BIOCQ

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.